🔴 Veraxa Biotech is trading 5.9% down as five-session slide extends

Veraxa Biotech is trading 5.89% down at $1.12 on October 2, 2026, as the immediate catalyst remains unclear.

• The decline extends a five-session slide, with closes falling from $1.41 on September 25 to $1.19 on October 1.
• The company’s investor-relations releases list September 4 as its latest release; broader U.S. markets are higher, so market direction does not explain the drop.